About this trial
This is a prospective, multicenter study designed to evaluate the benefits of an evening music-based intervention on sundowning syndrome in patients with Alzheimer's disease or related disorders in a Protect lLife Unit setting.
Eligibility criteria
Qualifiers
Signature of consent by the patient's legal guardian obtained after providing information
Patients aged 60 and over who meet the diagnostic criteria for Alzheimer's disease and related disorders, including mainly: Lewy body disease, frontotemporal lobar degeneration, progressive supranuclear palsy, corticobasal degeneration, vascular encephalopathy, alcoholic dementia, primary progressive aphasia syndrome, posterior cortical atrophy syndrome (France Alzheimer, 2024).
Patient living in a secure care unit
If taking psychotropic drugs, they must have been stable for 3 months
Disqualifiers
Refusal to participate
Participation in a study on a drug/medical device/treatment technique that may affect sleep or behavior.
Highly sedated patients,
Patients with acute medical instability,
Trial design
Treatments tested in this trial
- Test musicale intervention
- Controle: audio book
Treatment groups
Sponsors and collaborators
Centre Hospitalier Universitaire de Saint Etienne
Lead sponsor
Lyon Neuroscience Research Center (CRNL)
Collaborator